Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3

Background: Chemoresistance is a major obstacle to successful chemotherapy for human non-small cell lung cancer (NSCLC). Astragaloside IV, the component of

Keywords:

• Cell
• Cisplatin
• Diabetes mellitus
• Chemotherapy
• Oncology
• Astragaloside IV
• Lung cancer
• Internal medicine
• Biology
• Astragaloside
• Viability assay
• Sensitization
• In vitro
• Cancer research
• Cytotoxicity
• Biochemistry

• Correction
• Source
• Cite
• Save
• Machine Reading By IdeaReader